Finally, A Foundational Heart Failure Drug That Works Across the Spectrum of EF
SGLT2 inhibitor shines in landmark DELIVER trial
Source: medpagetoday.com
Stay updated with breaking news from Developer Astrazeneca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SGLT2 inhibitor shines in landmark DELIVER trial